U.S. Non-alcoholic Steatohepatitis Biomarkers Market – Emerging Growth and Opportunities
by The U.S. non-alcoholic steatohepatitis (NASH) biomarkers market was valued at USD 0.81billion in 2024 and is expected to reach USD 5.55 billion by 2033, advancing …